Global Pharmaceutical CMO and CDMO Market Growth (Status and Outlook) 2026-2032
The global Pharmaceutical CMO and CDMO market size is predicted to grow from US$ 155810 million in 2025 to US$ 263860 million in 2032; it is expected to grow at a CAGR of 8.0% from 2026 to 2032.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
The market driver is consistent development of blockbuster pharmaceuticals, increasing production outsourcing by pharmaceuticals companies. The increasing outsourcing trend in the pharmaceutical industry demonstrates the success of this business model, as CDMOs are increasingly becoming integral parts of pharmaceutical companies’ value chains.
LPI (LP Information)' newest research report, the “Pharmaceutical CMO and CDMO Industry Forecast” looks at past sales and reviews total world Pharmaceutical CMO and CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CMO and CDMO sales for 2026 through 2032. With Pharmaceutical CMO and CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CMO and CDMO industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical CMO and CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical CMO and CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CMO and CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CMO and CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CMO and CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CMO and CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
The market driver is consistent development of blockbuster pharmaceuticals, increasing production outsourcing by pharmaceuticals companies. The increasing outsourcing trend in the pharmaceutical industry demonstrates the success of this business model, as CDMOs are increasingly becoming integral parts of pharmaceutical companies’ value chains.
LPI (LP Information)' newest research report, the “Pharmaceutical CMO and CDMO Industry Forecast” looks at past sales and reviews total world Pharmaceutical CMO and CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CMO and CDMO sales for 2026 through 2032. With Pharmaceutical CMO and CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CMO and CDMO industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical CMO and CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical CMO and CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CMO and CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CMO and CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CMO and CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CMO and CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- API CMO and CDMO
- FDF CMO and CDMO
- Packaging CMO
- Clinical CDMO
- Pharmaceutical Company
- Biotechnology Company
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Catalent
- Thermo Fisher Scientific
- Samsung Biologics
- Fareva
- WuXi AppTech
- WuXi Biologics
- Siegfried
- FUJIFILM Diosynth Biotechnologies
- Asymchem
- Pfizer CentreOne
- Delpharm
- Recipharm
- AGC Pharma Chemicals
- Boehringer Ingelheim
- Vetter
- Curia
- Aenova
- Porton
- Piramal
- Strides Pharma
- NextPharma
- Famar
- Jubilant
- Alcami
- Euroapi
- Eurofins
- Avid Bioservices
- BioVectra
- CPL
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CMO and CDMO Market Size (2021-2032)
2.1.2 Pharmaceutical CMO and CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Pharmaceutical CMO and CDMO by Country/Region (2021, 2025 & 2032)
2.2 Pharmaceutical CMO and CDMO Segment by Type
2.2.1 API CMO and CDMO
2.2.2 FDF CMO and CDMO
2.2.3 Packaging CMO
2.2.4 Clinical CDMO
2.2.5 Pharmaceutical CMO and CDMO Market Size by Type
2.2.5.1 Pharmaceutical CMO and CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
2.3 Pharmaceutical CMO and CDMO Segment by Application
2.3.1 Pharmaceutical Company
2.3.2 Biotechnology Company
2.3.3 Other
2.3.4 Pharmaceutical CMO and CDMO Market Size by Application
2.3.4.1 Pharmaceutical CMO and CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
3 PHARMACEUTICAL CMO AND CDMO MARKET SIZE BY PLAYER
3.1 Pharmaceutical CMO and CDMO Market Size Market Share by Player
3.1.1 Global Pharmaceutical CMO and CDMO Revenue by Player (2021-2026)
3.1.2 Global Pharmaceutical CMO and CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Pharmaceutical CMO and CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CMO AND CDMO BY REGION
4.1 Pharmaceutical CMO and CDMO Market Size by Region (2021-2026)
4.2 Global Pharmaceutical CMO and CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical CMO and CDMO Market Size Growth (2021-2026)
4.4 APAC Pharmaceutical CMO and CDMO Market Size Growth (2021-2026)
4.5 Europe Pharmaceutical CMO and CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Pharmaceutical CMO and CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Pharmaceutical CMO and CDMO Market Size by Country (2021-2026)
5.2 Americas Pharmaceutical CMO and CDMO Market Size by Type (2021-2026)
5.3 Americas Pharmaceutical CMO and CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CMO and CDMO Market Size by Region (2021-2026)
6.2 APAC Pharmaceutical CMO and CDMO Market Size by Type (2021-2026)
6.3 APAC Pharmaceutical CMO and CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CMO and CDMO Market Size by Country (2021-2026)
7.2 Europe Pharmaceutical CMO and CDMO Market Size by Type (2021-2026)
7.3 Europe Pharmaceutical CMO and CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CMO and CDMO by Region (2021-2026)
8.2 Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CMO AND CDMO MARKET FORECAST
10.1 Global Pharmaceutical CMO and CDMO Forecast by Region (2027-2032)
10.1.1 Global Pharmaceutical CMO and CDMO Forecast by Region (2027-2032)
10.1.2 Americas Pharmaceutical CMO and CDMO Forecast
10.1.3 APAC Pharmaceutical CMO and CDMO Forecast
10.1.4 Europe Pharmaceutical CMO and CDMO Forecast
10.1.5 Middle East & Africa Pharmaceutical CMO and CDMO Forecast
10.2 Americas Pharmaceutical CMO and CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Pharmaceutical CMO and CDMO Forecast
10.2.2 Canada Market Pharmaceutical CMO and CDMO Forecast
10.2.3 Mexico Market Pharmaceutical CMO and CDMO Forecast
10.2.4 Brazil Market Pharmaceutical CMO and CDMO Forecast
10.3 APAC Pharmaceutical CMO and CDMO Forecast by Region (2027-2032)
10.3.1 China Pharmaceutical CMO and CDMO Market Forecast
10.3.2 Japan Market Pharmaceutical CMO and CDMO Forecast
10.3.3 Korea Market Pharmaceutical CMO and CDMO Forecast
10.3.4 Southeast Asia Market Pharmaceutical CMO and CDMO Forecast
10.3.5 India Market Pharmaceutical CMO and CDMO Forecast
10.3.6 Australia Market Pharmaceutical CMO and CDMO Forecast
10.4 Europe Pharmaceutical CMO and CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Pharmaceutical CMO and CDMO Forecast
10.4.2 France Market Pharmaceutical CMO and CDMO Forecast
10.4.3 UK Market Pharmaceutical CMO and CDMO Forecast
10.4.4 Italy Market Pharmaceutical CMO and CDMO Forecast
10.4.5 Russia Market Pharmaceutical CMO and CDMO Forecast
10.5 Middle East & Africa Pharmaceutical CMO and CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Pharmaceutical CMO and CDMO Forecast
10.5.2 South Africa Market Pharmaceutical CMO and CDMO Forecast
10.5.3 Israel Market Pharmaceutical CMO and CDMO Forecast
10.5.4 Turkey Market Pharmaceutical CMO and CDMO Forecast
10.6 Global Pharmaceutical CMO and CDMO Forecast by Type (2027-2032)
10.7 Global Pharmaceutical CMO and CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Pharmaceutical CMO and CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Pharmaceutical CMO and CDMO Product Offered
11.1.3 Lonza Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Pharmaceutical CMO and CDMO Product Offered
11.2.3 Catalent Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Pharmaceutical CMO and CDMO Product Offered
11.3.3 Thermo Fisher Scientific Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Information
11.4.2 Samsung Biologics Pharmaceutical CMO and CDMO Product Offered
11.4.3 Samsung Biologics Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Samsung Biologics Main Business Overview
11.4.5 Samsung Biologics Latest Developments
11.5 Fareva
11.5.1 Fareva Company Information
11.5.2 Fareva Pharmaceutical CMO and CDMO Product Offered
11.5.3 Fareva Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fareva Main Business Overview
11.5.5 Fareva Latest Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Information
11.6.2 WuXi AppTech Pharmaceutical CMO and CDMO Product Offered
11.6.3 WuXi AppTech Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 WuXi AppTech Main Business Overview
11.6.5 WuXi AppTech Latest Developments
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Information
11.7.2 WuXi Biologics Pharmaceutical CMO and CDMO Product Offered
11.7.3 WuXi Biologics Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 WuXi Biologics Main Business Overview
11.7.5 WuXi Biologics Latest Developments
11.8 Siegfried
11.8.1 Siegfried Company Information
11.8.2 Siegfried Pharmaceutical CMO and CDMO Product Offered
11.8.3 Siegfried Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Siegfried Main Business Overview
11.8.5 Siegfried Latest Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
11.9.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Product Offered
11.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.10 Asymchem
11.10.1 Asymchem Company Information
11.10.2 Asymchem Pharmaceutical CMO and CDMO Product Offered
11.10.3 Asymchem Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Asymchem Main Business Overview
11.10.5 Asymchem Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Pharmaceutical CMO and CDMO Product Offered
11.11.3 Pfizer CentreOne Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Delpharm
11.12.1 Delpharm Company Information
11.12.2 Delpharm Pharmaceutical CMO and CDMO Product Offered
11.12.3 Delpharm Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Delpharm Main Business Overview
11.12.5 Delpharm Latest Developments
11.13 Recipharm
11.13.1 Recipharm Company Information
11.13.2 Recipharm Pharmaceutical CMO and CDMO Product Offered
11.13.3 Recipharm Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Recipharm Main Business Overview
11.13.5 Recipharm Latest Developments
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Information
11.14.2 AGC Pharma Chemicals Pharmaceutical CMO and CDMO Product Offered
11.14.3 AGC Pharma Chemicals Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 AGC Pharma Chemicals Main Business Overview
11.14.5 AGC Pharma Chemicals Latest Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Information
11.15.2 Boehringer Ingelheim Pharmaceutical CMO and CDMO Product Offered
11.15.3 Boehringer Ingelheim Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Boehringer Ingelheim Main Business Overview
11.15.5 Boehringer Ingelheim Latest Developments
11.16 Vetter
11.16.1 Vetter Company Information
11.16.2 Vetter Pharmaceutical CMO and CDMO Product Offered
11.16.3 Vetter Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Vetter Main Business Overview
11.16.5 Vetter Latest Developments
11.17 Curia
11.17.1 Curia Company Information
11.17.2 Curia Pharmaceutical CMO and CDMO Product Offered
11.17.3 Curia Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Curia Main Business Overview
11.17.5 Curia Latest Developments
11.18 Aenova
11.18.1 Aenova Company Information
11.18.2 Aenova Pharmaceutical CMO and CDMO Product Offered
11.18.3 Aenova Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Aenova Main Business Overview
11.18.5 Aenova Latest Developments
11.19 Porton
11.19.1 Porton Company Information
11.19.2 Porton Pharmaceutical CMO and CDMO Product Offered
11.19.3 Porton Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Porton Main Business Overview
11.19.5 Porton Latest Developments
11.20 Piramal
11.20.1 Piramal Company Information
11.20.2 Piramal Pharmaceutical CMO and CDMO Product Offered
11.20.3 Piramal Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Piramal Main Business Overview
11.20.5 Piramal Latest Developments
11.21 Strides Pharma
11.21.1 Strides Pharma Company Information
11.21.2 Strides Pharma Pharmaceutical CMO and CDMO Product Offered
11.21.3 Strides Pharma Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Strides Pharma Main Business Overview
11.21.5 Strides Pharma Latest Developments
11.22 NextPharma
11.22.1 NextPharma Company Information
11.22.2 NextPharma Pharmaceutical CMO and CDMO Product Offered
11.22.3 NextPharma Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 NextPharma Main Business Overview
11.22.5 NextPharma Latest Developments
11.23 Famar
11.23.1 Famar Company Information
11.23.2 Famar Pharmaceutical CMO and CDMO Product Offered
11.23.3 Famar Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Famar Main Business Overview
11.23.5 Famar Latest Developments
11.24 Jubilant
11.24.1 Jubilant Company Information
11.24.2 Jubilant Pharmaceutical CMO and CDMO Product Offered
11.24.3 Jubilant Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Jubilant Main Business Overview
11.24.5 Jubilant Latest Developments
11.25 Alcami
11.25.1 Alcami Company Information
11.25.2 Alcami Pharmaceutical CMO and CDMO Product Offered
11.25.3 Alcami Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Alcami Main Business Overview
11.25.5 Alcami Latest Developments
11.26 Euroapi
11.26.1 Euroapi Company Information
11.26.2 Euroapi Pharmaceutical CMO and CDMO Product Offered
11.26.3 Euroapi Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Euroapi Main Business Overview
11.26.5 Euroapi Latest Developments
11.27 Eurofins
11.27.1 Eurofins Company Information
11.27.2 Eurofins Pharmaceutical CMO and CDMO Product Offered
11.27.3 Eurofins Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Eurofins Main Business Overview
11.27.5 Eurofins Latest Developments
11.28 Avid Bioservices
11.28.1 Avid Bioservices Company Information
11.28.2 Avid Bioservices Pharmaceutical CMO and CDMO Product Offered
11.28.3 Avid Bioservices Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Avid Bioservices Main Business Overview
11.28.5 Avid Bioservices Latest Developments
11.29 BioVectra
11.29.1 BioVectra Company Information
11.29.2 BioVectra Pharmaceutical CMO and CDMO Product Offered
11.29.3 BioVectra Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 BioVectra Main Business Overview
11.29.5 BioVectra Latest Developments
11.30 CPL
11.30.1 CPL Company Information
11.30.2 CPL Pharmaceutical CMO and CDMO Product Offered
11.30.3 CPL Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 CPL Main Business Overview
11.30.5 CPL Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CMO and CDMO Market Size (2021-2032)
2.1.2 Pharmaceutical CMO and CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Pharmaceutical CMO and CDMO by Country/Region (2021, 2025 & 2032)
2.2 Pharmaceutical CMO and CDMO Segment by Type
2.2.1 API CMO and CDMO
2.2.2 FDF CMO and CDMO
2.2.3 Packaging CMO
2.2.4 Clinical CDMO
2.2.5 Pharmaceutical CMO and CDMO Market Size by Type
2.2.5.1 Pharmaceutical CMO and CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
2.3 Pharmaceutical CMO and CDMO Segment by Application
2.3.1 Pharmaceutical Company
2.3.2 Biotechnology Company
2.3.3 Other
2.3.4 Pharmaceutical CMO and CDMO Market Size by Application
2.3.4.1 Pharmaceutical CMO and CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
3 PHARMACEUTICAL CMO AND CDMO MARKET SIZE BY PLAYER
3.1 Pharmaceutical CMO and CDMO Market Size Market Share by Player
3.1.1 Global Pharmaceutical CMO and CDMO Revenue by Player (2021-2026)
3.1.2 Global Pharmaceutical CMO and CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Pharmaceutical CMO and CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CMO AND CDMO BY REGION
4.1 Pharmaceutical CMO and CDMO Market Size by Region (2021-2026)
4.2 Global Pharmaceutical CMO and CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical CMO and CDMO Market Size Growth (2021-2026)
4.4 APAC Pharmaceutical CMO and CDMO Market Size Growth (2021-2026)
4.5 Europe Pharmaceutical CMO and CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Pharmaceutical CMO and CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Pharmaceutical CMO and CDMO Market Size by Country (2021-2026)
5.2 Americas Pharmaceutical CMO and CDMO Market Size by Type (2021-2026)
5.3 Americas Pharmaceutical CMO and CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CMO and CDMO Market Size by Region (2021-2026)
6.2 APAC Pharmaceutical CMO and CDMO Market Size by Type (2021-2026)
6.3 APAC Pharmaceutical CMO and CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CMO and CDMO Market Size by Country (2021-2026)
7.2 Europe Pharmaceutical CMO and CDMO Market Size by Type (2021-2026)
7.3 Europe Pharmaceutical CMO and CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CMO and CDMO by Region (2021-2026)
8.2 Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CMO AND CDMO MARKET FORECAST
10.1 Global Pharmaceutical CMO and CDMO Forecast by Region (2027-2032)
10.1.1 Global Pharmaceutical CMO and CDMO Forecast by Region (2027-2032)
10.1.2 Americas Pharmaceutical CMO and CDMO Forecast
10.1.3 APAC Pharmaceutical CMO and CDMO Forecast
10.1.4 Europe Pharmaceutical CMO and CDMO Forecast
10.1.5 Middle East & Africa Pharmaceutical CMO and CDMO Forecast
10.2 Americas Pharmaceutical CMO and CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Pharmaceutical CMO and CDMO Forecast
10.2.2 Canada Market Pharmaceutical CMO and CDMO Forecast
10.2.3 Mexico Market Pharmaceutical CMO and CDMO Forecast
10.2.4 Brazil Market Pharmaceutical CMO and CDMO Forecast
10.3 APAC Pharmaceutical CMO and CDMO Forecast by Region (2027-2032)
10.3.1 China Pharmaceutical CMO and CDMO Market Forecast
10.3.2 Japan Market Pharmaceutical CMO and CDMO Forecast
10.3.3 Korea Market Pharmaceutical CMO and CDMO Forecast
10.3.4 Southeast Asia Market Pharmaceutical CMO and CDMO Forecast
10.3.5 India Market Pharmaceutical CMO and CDMO Forecast
10.3.6 Australia Market Pharmaceutical CMO and CDMO Forecast
10.4 Europe Pharmaceutical CMO and CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Pharmaceutical CMO and CDMO Forecast
10.4.2 France Market Pharmaceutical CMO and CDMO Forecast
10.4.3 UK Market Pharmaceutical CMO and CDMO Forecast
10.4.4 Italy Market Pharmaceutical CMO and CDMO Forecast
10.4.5 Russia Market Pharmaceutical CMO and CDMO Forecast
10.5 Middle East & Africa Pharmaceutical CMO and CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Pharmaceutical CMO and CDMO Forecast
10.5.2 South Africa Market Pharmaceutical CMO and CDMO Forecast
10.5.3 Israel Market Pharmaceutical CMO and CDMO Forecast
10.5.4 Turkey Market Pharmaceutical CMO and CDMO Forecast
10.6 Global Pharmaceutical CMO and CDMO Forecast by Type (2027-2032)
10.7 Global Pharmaceutical CMO and CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Pharmaceutical CMO and CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Pharmaceutical CMO and CDMO Product Offered
11.1.3 Lonza Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Pharmaceutical CMO and CDMO Product Offered
11.2.3 Catalent Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Pharmaceutical CMO and CDMO Product Offered
11.3.3 Thermo Fisher Scientific Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Information
11.4.2 Samsung Biologics Pharmaceutical CMO and CDMO Product Offered
11.4.3 Samsung Biologics Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Samsung Biologics Main Business Overview
11.4.5 Samsung Biologics Latest Developments
11.5 Fareva
11.5.1 Fareva Company Information
11.5.2 Fareva Pharmaceutical CMO and CDMO Product Offered
11.5.3 Fareva Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fareva Main Business Overview
11.5.5 Fareva Latest Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Information
11.6.2 WuXi AppTech Pharmaceutical CMO and CDMO Product Offered
11.6.3 WuXi AppTech Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 WuXi AppTech Main Business Overview
11.6.5 WuXi AppTech Latest Developments
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Information
11.7.2 WuXi Biologics Pharmaceutical CMO and CDMO Product Offered
11.7.3 WuXi Biologics Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 WuXi Biologics Main Business Overview
11.7.5 WuXi Biologics Latest Developments
11.8 Siegfried
11.8.1 Siegfried Company Information
11.8.2 Siegfried Pharmaceutical CMO and CDMO Product Offered
11.8.3 Siegfried Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Siegfried Main Business Overview
11.8.5 Siegfried Latest Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
11.9.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Product Offered
11.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.10 Asymchem
11.10.1 Asymchem Company Information
11.10.2 Asymchem Pharmaceutical CMO and CDMO Product Offered
11.10.3 Asymchem Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Asymchem Main Business Overview
11.10.5 Asymchem Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Pharmaceutical CMO and CDMO Product Offered
11.11.3 Pfizer CentreOne Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Delpharm
11.12.1 Delpharm Company Information
11.12.2 Delpharm Pharmaceutical CMO and CDMO Product Offered
11.12.3 Delpharm Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Delpharm Main Business Overview
11.12.5 Delpharm Latest Developments
11.13 Recipharm
11.13.1 Recipharm Company Information
11.13.2 Recipharm Pharmaceutical CMO and CDMO Product Offered
11.13.3 Recipharm Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Recipharm Main Business Overview
11.13.5 Recipharm Latest Developments
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Information
11.14.2 AGC Pharma Chemicals Pharmaceutical CMO and CDMO Product Offered
11.14.3 AGC Pharma Chemicals Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 AGC Pharma Chemicals Main Business Overview
11.14.5 AGC Pharma Chemicals Latest Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Information
11.15.2 Boehringer Ingelheim Pharmaceutical CMO and CDMO Product Offered
11.15.3 Boehringer Ingelheim Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Boehringer Ingelheim Main Business Overview
11.15.5 Boehringer Ingelheim Latest Developments
11.16 Vetter
11.16.1 Vetter Company Information
11.16.2 Vetter Pharmaceutical CMO and CDMO Product Offered
11.16.3 Vetter Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Vetter Main Business Overview
11.16.5 Vetter Latest Developments
11.17 Curia
11.17.1 Curia Company Information
11.17.2 Curia Pharmaceutical CMO and CDMO Product Offered
11.17.3 Curia Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Curia Main Business Overview
11.17.5 Curia Latest Developments
11.18 Aenova
11.18.1 Aenova Company Information
11.18.2 Aenova Pharmaceutical CMO and CDMO Product Offered
11.18.3 Aenova Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Aenova Main Business Overview
11.18.5 Aenova Latest Developments
11.19 Porton
11.19.1 Porton Company Information
11.19.2 Porton Pharmaceutical CMO and CDMO Product Offered
11.19.3 Porton Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Porton Main Business Overview
11.19.5 Porton Latest Developments
11.20 Piramal
11.20.1 Piramal Company Information
11.20.2 Piramal Pharmaceutical CMO and CDMO Product Offered
11.20.3 Piramal Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Piramal Main Business Overview
11.20.5 Piramal Latest Developments
11.21 Strides Pharma
11.21.1 Strides Pharma Company Information
11.21.2 Strides Pharma Pharmaceutical CMO and CDMO Product Offered
11.21.3 Strides Pharma Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Strides Pharma Main Business Overview
11.21.5 Strides Pharma Latest Developments
11.22 NextPharma
11.22.1 NextPharma Company Information
11.22.2 NextPharma Pharmaceutical CMO and CDMO Product Offered
11.22.3 NextPharma Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 NextPharma Main Business Overview
11.22.5 NextPharma Latest Developments
11.23 Famar
11.23.1 Famar Company Information
11.23.2 Famar Pharmaceutical CMO and CDMO Product Offered
11.23.3 Famar Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Famar Main Business Overview
11.23.5 Famar Latest Developments
11.24 Jubilant
11.24.1 Jubilant Company Information
11.24.2 Jubilant Pharmaceutical CMO and CDMO Product Offered
11.24.3 Jubilant Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Jubilant Main Business Overview
11.24.5 Jubilant Latest Developments
11.25 Alcami
11.25.1 Alcami Company Information
11.25.2 Alcami Pharmaceutical CMO and CDMO Product Offered
11.25.3 Alcami Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Alcami Main Business Overview
11.25.5 Alcami Latest Developments
11.26 Euroapi
11.26.1 Euroapi Company Information
11.26.2 Euroapi Pharmaceutical CMO and CDMO Product Offered
11.26.3 Euroapi Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Euroapi Main Business Overview
11.26.5 Euroapi Latest Developments
11.27 Eurofins
11.27.1 Eurofins Company Information
11.27.2 Eurofins Pharmaceutical CMO and CDMO Product Offered
11.27.3 Eurofins Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Eurofins Main Business Overview
11.27.5 Eurofins Latest Developments
11.28 Avid Bioservices
11.28.1 Avid Bioservices Company Information
11.28.2 Avid Bioservices Pharmaceutical CMO and CDMO Product Offered
11.28.3 Avid Bioservices Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Avid Bioservices Main Business Overview
11.28.5 Avid Bioservices Latest Developments
11.29 BioVectra
11.29.1 BioVectra Company Information
11.29.2 BioVectra Pharmaceutical CMO and CDMO Product Offered
11.29.3 BioVectra Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 BioVectra Main Business Overview
11.29.5 BioVectra Latest Developments
11.30 CPL
11.30.1 CPL Company Information
11.30.2 CPL Pharmaceutical CMO and CDMO Product Offered
11.30.3 CPL Pharmaceutical CMO and CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 CPL Main Business Overview
11.30.5 CPL Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical CMO and CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Pharmaceutical CMO and CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of API CMO and CDMO
Table 4. Major Players of FDF CMO and CDMO
Table 5. Major Players of Packaging CMO
Table 6. Major Players of Clinical CDMO
Table 7. Pharmaceutical CMO and CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Table 10. Pharmaceutical CMO and CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Table 13. Global Pharmaceutical CMO and CDMO Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Pharmaceutical CMO and CDMO Revenue Market Share by Player (2021-2026)
Table 15. Pharmaceutical CMO and CDMO Key Players Head office and Products Offered
Table 16. Pharmaceutical CMO and CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Pharmaceutical CMO and CDMO Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Pharmaceutical CMO and CDMO Market Size Market Share by Region (2021-2026)
Table 21. Global Pharmaceutical CMO and CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Pharmaceutical CMO and CDMO Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Pharmaceutical CMO and CDMO Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Pharmaceutical CMO and CDMO Market Size Market Share by Country (2021-2026)
Table 25. Americas Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Table 27. Americas Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Table 29. APAC Pharmaceutical CMO and CDMO Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Pharmaceutical CMO and CDMO Market Size Market Share by Region (2021-2026)
Table 31. APAC Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Pharmaceutical CMO and CDMO Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Pharmaceutical CMO and CDMO Market Size Market Share by Country (2021-2026)
Table 35. Europe Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Pharmaceutical CMO and CDMO
Table 41. Key Market Challenges & Risks of Pharmaceutical CMO and CDMO
Table 42. Key Industry Trends of Pharmaceutical CMO and CDMO
Table 43. Global Pharmaceutical CMO and CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Pharmaceutical CMO and CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Pharmaceutical CMO and CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Pharmaceutical CMO and CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Lonza Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 48. Lonza Pharmaceutical CMO and CDMO Product Offered
Table 49. Lonza Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Catalent Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 53. Catalent Pharmaceutical CMO and CDMO Product Offered
Table 54. Catalent Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Pharmaceutical CMO and CDMO Product Offered
Table 59. Thermo Fisher Scientific Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Thermo Fisher Scientific Main Business
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. Samsung Biologics Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 63. Samsung Biologics Pharmaceutical CMO and CDMO Product Offered
Table 64. Samsung Biologics Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Samsung Biologics Main Business
Table 66. Samsung Biologics Latest Developments
Table 67. Fareva Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 68. Fareva Pharmaceutical CMO and CDMO Product Offered
Table 69. Fareva Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Fareva Main Business
Table 71. Fareva Latest Developments
Table 72. WuXi AppTech Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 73. WuXi AppTech Pharmaceutical CMO and CDMO Product Offered
Table 74. WuXi AppTech Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. WuXi AppTech Main Business
Table 76. WuXi AppTech Latest Developments
Table 77. WuXi Biologics Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 78. WuXi Biologics Pharmaceutical CMO and CDMO Product Offered
Table 79. WuXi Biologics Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. WuXi Biologics Main Business
Table 81. WuXi Biologics Latest Developments
Table 82. Siegfried Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 83. Siegfried Pharmaceutical CMO and CDMO Product Offered
Table 84. Siegfried Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Siegfried Main Business
Table 86. Siegfried Latest Developments
Table 87. FUJIFILM Diosynth Biotechnologies Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 88. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Product Offered
Table 89. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. FUJIFILM Diosynth Biotechnologies Main Business
Table 91. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 92. Asymchem Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 93. Asymchem Pharmaceutical CMO and CDMO Product Offered
Table 94. Asymchem Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Asymchem Main Business
Table 96. Asymchem Latest Developments
Table 97. Pfizer CentreOne Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 98. Pfizer CentreOne Pharmaceutical CMO and CDMO Product Offered
Table 99. Pfizer CentreOne Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Pfizer CentreOne Main Business
Table 101. Pfizer CentreOne Latest Developments
Table 102. Delpharm Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 103. Delpharm Pharmaceutical CMO and CDMO Product Offered
Table 104. Delpharm Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Delpharm Main Business
Table 106. Delpharm Latest Developments
Table 107. Recipharm Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 108. Recipharm Pharmaceutical CMO and CDMO Product Offered
Table 109. Recipharm Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Recipharm Main Business
Table 111. Recipharm Latest Developments
Table 112. AGC Pharma Chemicals Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 113. AGC Pharma Chemicals Pharmaceutical CMO and CDMO Product Offered
Table 114. AGC Pharma Chemicals Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. AGC Pharma Chemicals Main Business
Table 116. AGC Pharma Chemicals Latest Developments
Table 117. Boehringer Ingelheim Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 118. Boehringer Ingelheim Pharmaceutical CMO and CDMO Product Offered
Table 119. Boehringer Ingelheim Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Boehringer Ingelheim Main Business
Table 121. Boehringer Ingelheim Latest Developments
Table 122. Vetter Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 123. Vetter Pharmaceutical CMO and CDMO Product Offered
Table 124. Vetter Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Vetter Main Business
Table 126. Vetter Latest Developments
Table 127. Curia Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 128. Curia Pharmaceutical CMO and CDMO Product Offered
Table 129. Curia Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Curia Main Business
Table 131. Curia Latest Developments
Table 132. Aenova Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 133. Aenova Pharmaceutical CMO and CDMO Product Offered
Table 134. Aenova Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Aenova Main Business
Table 136. Aenova Latest Developments
Table 137. Porton Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 138. Porton Pharmaceutical CMO and CDMO Product Offered
Table 139. Porton Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Porton Main Business
Table 141. Porton Latest Developments
Table 142. Piramal Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 143. Piramal Pharmaceutical CMO and CDMO Product Offered
Table 144. Piramal Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Piramal Main Business
Table 146. Piramal Latest Developments
Table 147. Strides Pharma Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 148. Strides Pharma Pharmaceutical CMO and CDMO Product Offered
Table 149. Strides Pharma Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Strides Pharma Main Business
Table 151. Strides Pharma Latest Developments
Table 152. NextPharma Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 153. NextPharma Pharmaceutical CMO and CDMO Product Offered
Table 154. NextPharma Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. NextPharma Main Business
Table 156. NextPharma Latest Developments
Table 157. Famar Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 158. Famar Pharmaceutical CMO and CDMO Product Offered
Table 159. Famar Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. Famar Main Business
Table 161. Famar Latest Developments
Table 162. Jubilant Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 163. Jubilant Pharmaceutical CMO and CDMO Product Offered
Table 164. Jubilant Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 165. Jubilant Main Business
Table 166. Jubilant Latest Developments
Table 167. Alcami Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 168. Alcami Pharmaceutical CMO and CDMO Product Offered
Table 169. Alcami Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 170. Alcami Main Business
Table 171. Alcami Latest Developments
Table 172. Euroapi Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 173. Euroapi Pharmaceutical CMO and CDMO Product Offered
Table 174. Euroapi Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 175. Euroapi Main Business
Table 176. Euroapi Latest Developments
Table 177. Eurofins Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 178. Eurofins Pharmaceutical CMO and CDMO Product Offered
Table 179. Eurofins Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 180. Eurofins Main Business
Table 181. Eurofins Latest Developments
Table 182. Avid Bioservices Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 183. Avid Bioservices Pharmaceutical CMO and CDMO Product Offered
Table 184. Avid Bioservices Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 185. Avid Bioservices Main Business
Table 186. Avid Bioservices Latest Developments
Table 187. BioVectra Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 188. BioVectra Pharmaceutical CMO and CDMO Product Offered
Table 189. BioVectra Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 190. BioVectra Main Business
Table 191. BioVectra Latest Developments
Table 192. CPL Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 193. CPL Pharmaceutical CMO and CDMO Product Offered
Table 194. CPL Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 195. CPL Main Business
Table 196. CPL Latest Developments
Table 1. Pharmaceutical CMO and CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Pharmaceutical CMO and CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of API CMO and CDMO
Table 4. Major Players of FDF CMO and CDMO
Table 5. Major Players of Packaging CMO
Table 6. Major Players of Clinical CDMO
Table 7. Pharmaceutical CMO and CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Table 10. Pharmaceutical CMO and CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Table 13. Global Pharmaceutical CMO and CDMO Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Pharmaceutical CMO and CDMO Revenue Market Share by Player (2021-2026)
Table 15. Pharmaceutical CMO and CDMO Key Players Head office and Products Offered
Table 16. Pharmaceutical CMO and CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Pharmaceutical CMO and CDMO Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Pharmaceutical CMO and CDMO Market Size Market Share by Region (2021-2026)
Table 21. Global Pharmaceutical CMO and CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Pharmaceutical CMO and CDMO Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Pharmaceutical CMO and CDMO Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Pharmaceutical CMO and CDMO Market Size Market Share by Country (2021-2026)
Table 25. Americas Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Table 27. Americas Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Table 29. APAC Pharmaceutical CMO and CDMO Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Pharmaceutical CMO and CDMO Market Size Market Share by Region (2021-2026)
Table 31. APAC Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Pharmaceutical CMO and CDMO Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Pharmaceutical CMO and CDMO Market Size Market Share by Country (2021-2026)
Table 35. Europe Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Pharmaceutical CMO and CDMO
Table 41. Key Market Challenges & Risks of Pharmaceutical CMO and CDMO
Table 42. Key Industry Trends of Pharmaceutical CMO and CDMO
Table 43. Global Pharmaceutical CMO and CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Pharmaceutical CMO and CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Pharmaceutical CMO and CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Pharmaceutical CMO and CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Lonza Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 48. Lonza Pharmaceutical CMO and CDMO Product Offered
Table 49. Lonza Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Catalent Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 53. Catalent Pharmaceutical CMO and CDMO Product Offered
Table 54. Catalent Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Pharmaceutical CMO and CDMO Product Offered
Table 59. Thermo Fisher Scientific Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Thermo Fisher Scientific Main Business
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. Samsung Biologics Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 63. Samsung Biologics Pharmaceutical CMO and CDMO Product Offered
Table 64. Samsung Biologics Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Samsung Biologics Main Business
Table 66. Samsung Biologics Latest Developments
Table 67. Fareva Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 68. Fareva Pharmaceutical CMO and CDMO Product Offered
Table 69. Fareva Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Fareva Main Business
Table 71. Fareva Latest Developments
Table 72. WuXi AppTech Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 73. WuXi AppTech Pharmaceutical CMO and CDMO Product Offered
Table 74. WuXi AppTech Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. WuXi AppTech Main Business
Table 76. WuXi AppTech Latest Developments
Table 77. WuXi Biologics Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 78. WuXi Biologics Pharmaceutical CMO and CDMO Product Offered
Table 79. WuXi Biologics Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. WuXi Biologics Main Business
Table 81. WuXi Biologics Latest Developments
Table 82. Siegfried Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 83. Siegfried Pharmaceutical CMO and CDMO Product Offered
Table 84. Siegfried Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Siegfried Main Business
Table 86. Siegfried Latest Developments
Table 87. FUJIFILM Diosynth Biotechnologies Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 88. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Product Offered
Table 89. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. FUJIFILM Diosynth Biotechnologies Main Business
Table 91. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 92. Asymchem Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 93. Asymchem Pharmaceutical CMO and CDMO Product Offered
Table 94. Asymchem Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Asymchem Main Business
Table 96. Asymchem Latest Developments
Table 97. Pfizer CentreOne Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 98. Pfizer CentreOne Pharmaceutical CMO and CDMO Product Offered
Table 99. Pfizer CentreOne Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Pfizer CentreOne Main Business
Table 101. Pfizer CentreOne Latest Developments
Table 102. Delpharm Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 103. Delpharm Pharmaceutical CMO and CDMO Product Offered
Table 104. Delpharm Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Delpharm Main Business
Table 106. Delpharm Latest Developments
Table 107. Recipharm Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 108. Recipharm Pharmaceutical CMO and CDMO Product Offered
Table 109. Recipharm Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Recipharm Main Business
Table 111. Recipharm Latest Developments
Table 112. AGC Pharma Chemicals Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 113. AGC Pharma Chemicals Pharmaceutical CMO and CDMO Product Offered
Table 114. AGC Pharma Chemicals Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. AGC Pharma Chemicals Main Business
Table 116. AGC Pharma Chemicals Latest Developments
Table 117. Boehringer Ingelheim Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 118. Boehringer Ingelheim Pharmaceutical CMO and CDMO Product Offered
Table 119. Boehringer Ingelheim Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Boehringer Ingelheim Main Business
Table 121. Boehringer Ingelheim Latest Developments
Table 122. Vetter Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 123. Vetter Pharmaceutical CMO and CDMO Product Offered
Table 124. Vetter Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Vetter Main Business
Table 126. Vetter Latest Developments
Table 127. Curia Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 128. Curia Pharmaceutical CMO and CDMO Product Offered
Table 129. Curia Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Curia Main Business
Table 131. Curia Latest Developments
Table 132. Aenova Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 133. Aenova Pharmaceutical CMO and CDMO Product Offered
Table 134. Aenova Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Aenova Main Business
Table 136. Aenova Latest Developments
Table 137. Porton Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 138. Porton Pharmaceutical CMO and CDMO Product Offered
Table 139. Porton Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Porton Main Business
Table 141. Porton Latest Developments
Table 142. Piramal Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 143. Piramal Pharmaceutical CMO and CDMO Product Offered
Table 144. Piramal Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Piramal Main Business
Table 146. Piramal Latest Developments
Table 147. Strides Pharma Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 148. Strides Pharma Pharmaceutical CMO and CDMO Product Offered
Table 149. Strides Pharma Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Strides Pharma Main Business
Table 151. Strides Pharma Latest Developments
Table 152. NextPharma Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 153. NextPharma Pharmaceutical CMO and CDMO Product Offered
Table 154. NextPharma Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. NextPharma Main Business
Table 156. NextPharma Latest Developments
Table 157. Famar Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 158. Famar Pharmaceutical CMO and CDMO Product Offered
Table 159. Famar Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. Famar Main Business
Table 161. Famar Latest Developments
Table 162. Jubilant Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 163. Jubilant Pharmaceutical CMO and CDMO Product Offered
Table 164. Jubilant Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 165. Jubilant Main Business
Table 166. Jubilant Latest Developments
Table 167. Alcami Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 168. Alcami Pharmaceutical CMO and CDMO Product Offered
Table 169. Alcami Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 170. Alcami Main Business
Table 171. Alcami Latest Developments
Table 172. Euroapi Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 173. Euroapi Pharmaceutical CMO and CDMO Product Offered
Table 174. Euroapi Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 175. Euroapi Main Business
Table 176. Euroapi Latest Developments
Table 177. Eurofins Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 178. Eurofins Pharmaceutical CMO and CDMO Product Offered
Table 179. Eurofins Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 180. Eurofins Main Business
Table 181. Eurofins Latest Developments
Table 182. Avid Bioservices Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 183. Avid Bioservices Pharmaceutical CMO and CDMO Product Offered
Table 184. Avid Bioservices Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 185. Avid Bioservices Main Business
Table 186. Avid Bioservices Latest Developments
Table 187. BioVectra Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 188. BioVectra Pharmaceutical CMO and CDMO Product Offered
Table 189. BioVectra Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 190. BioVectra Main Business
Table 191. BioVectra Latest Developments
Table 192. CPL Details, Company Type, Pharmaceutical CMO and CDMO Area Served and Its Competitors
Table 193. CPL Pharmaceutical CMO and CDMO Product Offered
Table 194. CPL Pharmaceutical CMO and CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 195. CPL Main Business
Table 196. CPL Latest Developments
LIST OF FIGURES
Figure 1. Pharmaceutical CMO and CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CMO and CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Pharmaceutical CMO and CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Pharmaceutical CMO and CDMO Sales Market Share by Country/Region (2025)
Figure 8. Pharmaceutical CMO and CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Pharmaceutical CMO and CDMO Market Size Market Share by Type in 2025
Figure 10. Pharmaceutical CMO and CDMO in Pharmaceutical Company
Figure 11. Global Pharmaceutical CMO and CDMO Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 12. Pharmaceutical CMO and CDMO in Biotechnology Company
Figure 13. Global Pharmaceutical CMO and CDMO Market: Biotechnology Company (2021-2026) & ($ millions)
Figure 14. Pharmaceutical CMO and CDMO in Other
Figure 15. Global Pharmaceutical CMO and CDMO Market: Other (2021-2026) & ($ millions)
Figure 16. Global Pharmaceutical CMO and CDMO Market Size Market Share by Application in 2025
Figure 17. Global Pharmaceutical CMO and CDMO Revenue Market Share by Player in 2025
Figure 18. Global Pharmaceutical CMO and CDMO Market Size Market Share by Region (2021-2026)
Figure 19. Americas Pharmaceutical CMO and CDMO Market Size 2021-2026 ($ millions)
Figure 20. APAC Pharmaceutical CMO and CDMO Market Size 2021-2026 ($ millions)
Figure 21. Europe Pharmaceutical CMO and CDMO Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Pharmaceutical CMO and CDMO Market Size 2021-2026 ($ millions)
Figure 23. Americas Pharmaceutical CMO and CDMO Value Market Share by Country in 2025
Figure 24. United States Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Pharmaceutical CMO and CDMO Market Size Market Share by Region in 2025
Figure 29. APAC Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Figure 30. APAC Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Figure 31. China Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. India Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Pharmaceutical CMO and CDMO Market Size Market Share by Country in 2025
Figure 38. Europe Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Figure 39. Europe Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Figure 40. Germany Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. France Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Pharmaceutical CMO and CDMO Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 54. APAC Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 55. Europe Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 57. United States Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 58. Canada Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 59. Mexico Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 60. Brazil Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 61. China Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 62. Japan Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 63. Korea Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 65. India Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 66. Australia Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 67. Germany Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 68. France Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 69. UK Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 70. Italy Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 71. Russia Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 72. Egypt Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 73. South Africa Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 74. Israel Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 75. Turkey Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 76. Global Pharmaceutical CMO and CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Pharmaceutical CMO and CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 1. Pharmaceutical CMO and CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CMO and CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Pharmaceutical CMO and CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Pharmaceutical CMO and CDMO Sales Market Share by Country/Region (2025)
Figure 8. Pharmaceutical CMO and CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Pharmaceutical CMO and CDMO Market Size Market Share by Type in 2025
Figure 10. Pharmaceutical CMO and CDMO in Pharmaceutical Company
Figure 11. Global Pharmaceutical CMO and CDMO Market: Pharmaceutical Company (2021-2026) & ($ millions)
Figure 12. Pharmaceutical CMO and CDMO in Biotechnology Company
Figure 13. Global Pharmaceutical CMO and CDMO Market: Biotechnology Company (2021-2026) & ($ millions)
Figure 14. Pharmaceutical CMO and CDMO in Other
Figure 15. Global Pharmaceutical CMO and CDMO Market: Other (2021-2026) & ($ millions)
Figure 16. Global Pharmaceutical CMO and CDMO Market Size Market Share by Application in 2025
Figure 17. Global Pharmaceutical CMO and CDMO Revenue Market Share by Player in 2025
Figure 18. Global Pharmaceutical CMO and CDMO Market Size Market Share by Region (2021-2026)
Figure 19. Americas Pharmaceutical CMO and CDMO Market Size 2021-2026 ($ millions)
Figure 20. APAC Pharmaceutical CMO and CDMO Market Size 2021-2026 ($ millions)
Figure 21. Europe Pharmaceutical CMO and CDMO Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Pharmaceutical CMO and CDMO Market Size 2021-2026 ($ millions)
Figure 23. Americas Pharmaceutical CMO and CDMO Value Market Share by Country in 2025
Figure 24. United States Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Pharmaceutical CMO and CDMO Market Size Market Share by Region in 2025
Figure 29. APAC Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Figure 30. APAC Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Figure 31. China Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. India Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Pharmaceutical CMO and CDMO Market Size Market Share by Country in 2025
Figure 38. Europe Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Figure 39. Europe Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Figure 40. Germany Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. France Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Pharmaceutical CMO and CDMO Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Pharmaceutical CMO and CDMO Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Pharmaceutical CMO and CDMO Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Pharmaceutical CMO and CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 54. APAC Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 55. Europe Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 57. United States Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 58. Canada Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 59. Mexico Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 60. Brazil Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 61. China Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 62. Japan Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 63. Korea Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 65. India Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 66. Australia Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 67. Germany Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 68. France Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 69. UK Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 70. Italy Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 71. Russia Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 72. Egypt Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 73. South Africa Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 74. Israel Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 75. Turkey Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
Figure 76. Global Pharmaceutical CMO and CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Pharmaceutical CMO and CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Pharmaceutical CMO and CDMO Market Size 2027-2032 ($ millions)
